Bishal Gyawali

Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 44

Top Topics

Childhood Cancer

Helicobacter Pylori

Metastatic Renal Cell Carcinoma

Top Venues

JCO global oncology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

JCO oncology practice

Nature reviews. Clinical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Nina Niu Sanford, Bishal Gyawali
Financial Conflicts of Interest: Payment at the Expense of Patients? JCO oncology practice 20 (6) (2024)
Christopher M Booth, Elizabeth A Eisenhauer, Bishal Gyawali, Ian F Tannock
Reply to D.J. Stewart et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Christopher M Booth, Elizabeth A Eisenhauer, Bishal Gyawali, Ian F Tannock
Reply to D.J. Stewart et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (8) (2024)
Christopher M Booth, Elizabeth A Eisenhauer, Bishal Gyawali, Ian F Tannock
Reply to D.J. Stewart et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (8) (2024)
Nina Niu Sanford, Bishal Gyawali
Financial Conflicts of Interest: Payment at the Expense of Patients? JCO oncology practice (2024)
Christopher M Booth, Elizabeth A Eisenhauer, Bishal Gyawali, Ian F Tannock
Progression-Free Survival Should Not Be Used as a Primary End Point for Registration of Anticancer Drugs. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Bogda Koczwara, Alexandre Chan, Michael Jefford, Wendy Wing Tak Lam, Carolyn Taylor, Claire E Wakefield, Nirmala Bhoo Pathy, Bishal Gyawali, Gregory Harvet, Yan Lou, Conjeevaram S Pramesh, Miyako Takahashi, Yu Ke, William Ying Khee Hwang
Cancer Survivorship in the Indo-Pacific: Priorities for Progress. JCO global oncology 9 (2023)
Mufiza Farid-Kapadia, Madelyn Barton, Zoe Bider-Canfield, Parneet K Cheema, Bishal Gyawali, Natalie M Nightingale, Lidija Latifovic, Henry J Conter
Comparison of tumor-agnostic and tumor-specific clinical oncology trial designs: a systematic review and meta-analysis. Future oncology (London, England) (2023)
Ian F Tannock, Daniel A Goldstein, Jonathan Ofer, Bishal Gyawali, Tomer Meirson
Evaluating Trials of Adjuvant Therapy: Is There Benefit for People With Resected Renal Cancer? Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Bishal Gyawali
Problematic crossovers in cancer drug trials. Nature reviews. Clinical oncology (2023)
Sarith Ranawaka, Sathika Gunarathna, Sanjeeva Gunasekera, Christopher M Booth, Matthew Jalink, Laura M Carson, Scott Berry, Bishal Gyawali, Sanjeewa Anuruddha Seneviratne, Don Thiwanka Wijeratne
Breast Cancer-Related Financial Toxicity in Sri Lanka: Insights From a Lower Middle-Income Country With Free Universal Public Healthcare. The oncologist (2023)
Bishal Gyawali, Aaron S Kesselheim, Joseph R Ross
The Accelerated Approval Program for Cancer Drugs - Finding the Right Balance. The New England journal of medicine (2023)
Bishal Gyawali, Laura Mae Carson, Sian Shuel, Anna Nathalie Wilkinson, Heather Ostic, Colleen Savage, Scott Berry
Training General Practitioners in Oncology: Lessons Learned From a Cross-Sectional Survey of GPOs in Canada. JCO global oncology 9 (2023)
Howard Jack West, Amol Akhade, Bishal Gyawali
Could We Have Improved on ADAURA? Refining Global Research Practices to Reduce Cancer Care Disparities. JCO global oncology 9 (2023)
Bogda Koczwara, Alexandre Chan, Michael Jefford, Wendy Wing Tak Lam, Carolyn Taylor, Claire E Wakefield, Nirmala Bhoo Pathy, Bishal Gyawali, Gregory Harvet, Yan Lou, Conjeevaram S Pramesh, Miyako Takahashi, Yu Ke, William Ying Khee Hwang
Cancer Survivorship in the Indo-Pacific: Priorities for Progress. JCO global oncology 9 (2023)
Bogda Koczwara, Alexandre Chan, Michael Jefford, Wendy Wing Tak Lam, Carolyn Taylor, Claire E Wakefield, Nirmala Bhoo Pathy, Bishal Gyawali, Gregory Harvet, Yan Lou, Conjeevaram S Pramesh, Miyako Takahashi, Yu Ke, William Ying Khee Hwang
Reply to E.C. Dee et al. JCO global oncology 9 (2023)
Bishal Gyawali, Laura Mae Carson, Sian Shuel, Anna Nathalie Wilkinson, Heather Ostic, Colleen Savage, Scott Berry
Training General Practitioners in Oncology: Lessons Learned From a Cross-Sectional Survey of GPOs in Canada. JCO global oncology 9 (2023)
Bishal Gyawali, Gauthier Bouche, Nigel Crisp, Nicolas André
Challenges and opportunities for cancer clinical trials in low- and middle-income countries. Nature cancer 1 (2) (2022)
Shah Zeb Khan, Luca Arecco, Cynthia Villarreal Garza, Bhawna Sirohi, Noam F Ponde, Baker Shalal Habeeb, Mariana Brandão, Hatem A Azim, Arman Reza Chowdhury, Ivana Bozovic-Spasojevic, Iryna Kovalenko, Andrew Odhiambo, Fahmi Usman Seid, Alex Baleka Mutombo, Fernando Enrique Petracci, Radu Vidra, Sara C Altuna, Mila Petrova, Hampig Raphael Kourie, Mehmet Akif Ozturk, Maria Grazia Razeti, Csongor György Lengyel, Narmin Talibova, Elene Mariamidze, Karina Perez Sacardo, Narjust Florez, Bishal Gyawali, Dario Trapani, Marco Tagliamento, Matteo Lambertini
Knowledge, Practice, and Attitudes of Physicians in Low- and Middle-Income Countries on Fertility and Pregnancy-Related Issues in Young Women With Breast Cancer. JCO global oncology 8 (2022)
Manju Sengar, Adam M Fundytus, Wilma M Hopman, Conjeevaram S Pramesh, Venkatraman Radhakrishnan, Prasanth Ganesan, Aju Mathew, Dorothy Chilambe Lombe, Matthew Jalink, Bishal Gyawali, Dario Trapani, Felipe Santa Rosa Roitberg, Elisabeth G E De Vries, Lorenzo Moja, Gerald W Prager, Richard Sullivan, Christopher M Booth
Cancer Medicines: What Is Essential and Affordable in India? JCO global oncology 8 (2022)
Charu Aggarwal, Bishal Gyawali
Aumolertinib in EGFR -Mutant Lung Cancer: Will the Promise of Cost Disruption Ease Access ? Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (27) (2022)
Paul Istasy, Wen Shen Lee, Alla Iansavichene, Ross E G Uphsur, Bishal Gyawali, Jacquelyn Burkell, Bekim Sadikovic, Alejandro Lazo-Langner, Benjamin Chin-Yee
The Impact of Artificial Intelligence on Health Equity in Oncology: Scoping Review. Journal of medical Internet research 24 (11) (2022)
Avram E Denburg, Adam M Fundytus, Muhammad Saghir Khan, Scott C Howard, Federico Antillon-Klussmann, Manju Sengar, Dorothy Chilambe Lombe, Wilma M Hopman, Matthew Jalink, Bishal Gyawali, Dario Trapani, Felipe Santa Rosa Roitberg, Elisabeth G E De Vries, Lorenzo Moja, Gerald W Prager, Richard Sullivan, Christopher M Booth
Defining Essential Childhood Cancer Medicines to Inform Prioritization and Access: Results From an International, Cross-Sectional Survey. JCO global oncology 8 (2022)
Kristin Wright, Daniel E Meyers, Timothy M Chisamore, Matthew D F McInnes, Sergio Sismondo, Bishal Gyawali, Vinay Prasad, Christopher M Booth
Industry Relationships With Medical Oncologists: Who Are the High-Payment Physicians? JCO oncology practice 18 (7) (2022)
Bishal Gyawali, Christopher M Booth
Cancer treatments should benefit patients: a common-sense revolution in oncology. Nature medicine 28 (4) (2022)
Bishal Gyawali, Niresh Thapa, Colleen Savage, Laura Mae Carson, Matthew Jalink, Mangal Rawal, Scott Berry, Bishesh S Poudyal
Training General Practitioners in Oncology: A Needs Assessment Survey From Nepal. JCO global oncology 8 (2022)
Don Thiwanka Wijeratne, Sanjeeva Gunasekera, Christopher M Booth, Scott Berry, Matthew Jalink, Laura Mae Carson, Bishal Gyawali, Hasitha Promod, Umesh Jayarajah, Sanjeewa Anuruddha Seneviratne
Colorectal Cancer Treatment Characteristics and Concordance With Guidelines in Sri Lanka: Results From a Hospital-Based Cancer Registry. JCO global oncology 8 (2022)
Bishal Gyawali, Christopher M Booth
Defining clinically important overall survival thresholds: lessons from quality of life. Nature reviews. Clinical oncology 19 (10) (2022)
Adi Kartolo, Bishal Gyawali
Should the control arms of randomized trials have an expiry date? Nature reviews. Clinical oncology 19 (7) (2022)
Simon Van Wambeke, Francisco Emilio Vera-Badillo, Bishal Gyawali
Controlling the Control Arm in Metastatic Castration-Resistant Prostate Cancer Trials: Best Standard of Care or the Minimum Standard of Care? Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (14) (2022)
Shaila J Merchant, Weidong Kong, Bishal Gyawali, Timothy P Hanna, Wiley Chung, Sulaiman Nanji, Sunil V Patel, Christopher M Booth
First-Line Palliative Chemotherapy for Esophageal and Gastric Cancer: Practice Patterns and Outcomes in the General Population. JCO oncology practice 17 (10) (2021)
Karolina Strzebonska, Mateusz T Wasylewski, Lucja Zaborowska, Maciej Polak, Emilia Slugocka, Jakub Stras, Mateusz Blukacz, Bishal Gyawali, Marcin Waligora
Risk and Benefit for Targeted Therapy Agents in Pediatric Phase II Trials in Oncology: A Systematic Review with a Meta-Analysis. Targeted oncology 16 (4) (2021)
Ranjeeta Subedi, Meghnath Dhimal, Atul Madhukar Budukh, Sandhya Chapagain, Pradeep Gyawali, Bishal Gyawali, Uma Dahal, Rajesh Dikshit, Anjani Kumar Jha
Epidemiologic Pattern of Cancer in Kathmandu Valley, Nepal: Findings of Population-Based Cancer Registry, 2018. JCO global oncology 7 (2021)
Bishal Gyawali, Benjamin N Rome, Aaron S Kesselheim
Regulatory and clinical consequences of negative confirmatory trials of accelerated approval cancer drugs: retrospective observational study. BMJ (Clinical research ed.) 374 (2021)
Don Thiwanka Wijeratne, Kristin Wright, Bishal Gyawali
Risk-Stratifying Treatment Strategies for Febrile Neutropenia-Tools, Tools Everywhere, and Not a Single One That Works? JCO oncology practice 17 (11) (2021)
Bishal Gyawali, Aaron S Kesselheim
FDA approval standards for anticancer agents - lessons from two recent approvals in breast cancer. Nature reviews. Clinical oncology 18 (7) (2021)
Ophira Ginsburg, Cheng-Har Yip, Ari Brooks, Anna Cabanes, Mayra Caleffi Pereira, Jorge Antonio Dunstan Yataco, Bishal Gyawali, Valerie McCormack, Myrna McLaughlin de Anderson, Ravi Mehrotra, Alejandro Mohar, Rául Murillo, Lydia E Pace, Electra D Paskett, Anya Romanoff, Anne F Rositch, John R Scheel, Miriam Schneidman, Karla Unger-Saldaña, Verna D Vanderpuye, Tsu-Yin Wu, Safina Yuma, Allison Dvaladze, Catherine Duggan, Benjamin O Anderson
Breast cancer early detection: A phased approach to implementation. Cancer (2021)
Soumitra Shankar Datta, Arnab Mukherjee, Soumita Ghose, Sanjay Bhattacharya, Bishal Gyawali
Addressing the Mental Health Challenges of Cancer Care Workers in LMICs During the Time of the COVID-19 Pandemic. JCO global oncology 6 (2020)
Bishal Gyawali, Aaron S Kesselheim
The promise of ESCAT: a new system for evaluating cancer drug-target pairs. Nature reviews. Clinical oncology 16 (3) (2019)
Ronac Mamtani, Xin Victoria Wang, Bishal Gyawali, Robert S DiPaola, C Neill Epperson, Naomi B Haas, Janice P Dutcher
Association between age and sex and mortality after adjuvant therapy for renal cancer. Cancer 125 (10) (2019)
Thomas J Hwang, Bishal Gyawali
Association between progression-free survival and patients' quality of life in cancer clinical trials. International journal of cancer 144 (7) (2018)
Bishal Gyawali, Alfredo Addeo
Negative phase 3 randomized controlled trials: Why cancer drugs fail the last barrier? International journal of cancer 143 (8) (2018)
Bishal Gyawali, Aaron S Kesselheim, Elvira D'Andrea
Does Helicobacter pylori eradication therapy to prevent gastric cancer increase all-cause mortality? International journal of cancer 144 (2) (2018)
Bishal Gyawali, Tomoya Shimokata, Kazunori Honda, Hiroaki Tsukuura, Yuichi Ando
Should low-income countries invest in breast cancer screening? Cancer causes & control : CCC 27 (11) (2016)
Bishesh Sharma Poudyal, Bishal Gyawali, Sampurna Tuladhar, Kabita Kapali, Gentle S Shrestha
Inspiration amidst the challenges: the first report of successful bone marrow transplantation in the Himalayan country Nepal. British journal of haematology 173 (6) (2015)